Eastwood Bio-Medical Canada Inc (EBM) — Cash Flow Reinvestment Rate
Eastwood Bio-Medical Canada Inc (EBM) has a Cash Flow Reinvestment Rate of 0.00x as of April 2026, reinvesting CA$0.00 (capex CA$0.00 ) from operating cash flow of CA$2.26K. See Eastwood Bio-Medical Canada Inc (EBM) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Eastwood Bio-Medical Canada Inc Cash Flow Reinvestment Rate (2014–2025)
Historical reinvestment intensity for Eastwood Bio-Medical Canada Inc across 2 annual periods. For the full cash flow conversion analysis, see Eastwood Bio-Medical Canada Inc cash flow conversion.
Annual Cash Flow Reinvestment Rate for Eastwood Bio-Medical Canada Inc (2014–2025)
Year-by-year capital reinvestment analysis for Eastwood Bio-Medical Canada Inc. See Eastwood Bio-Medical Canada Inc (EBM) financial flexibility to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CAD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.00x | CA$0.00 | CA$19.30K | CA$0.00 | ▼ -100.0% |
| 2014 | 0.35x | CA$550.00K | CA$1.58 Million | CA$0.00 | — |